A clinical trial to study the effects of Aflibercept in patients with type 2 diabetes mellitus with reduced vision.
Phase 4
- Conditions
- Diabetic Macular Edema
- Registration Number
- JPRN-UMIN000051561
- Lead Sponsor
- MMU Mullana Ambala
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with proliferative diabetic retinopathy, prior intravitreal injections of anti-VEGFs or laser photocoagulation, pars plana vitrectomy, age-related macular degeneration, venous occlusion, ocular trauma, pregnancy, and ocular surgery (except cataract surgery) were excluded. Patients with less than 6 months follow-up after the 3rd injection were excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in subfoveal thickness after intravitreal Aflibercept
- Secondary Outcome Measures
Name Time Method Improvement in vision after intervention